First Bank & Trust’s GSK GSK Stock Holding History

First Bank & Trust’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.18M	Sell	41,519 -6,252	-13%	-$331K	0.32%	66
2026 Q1	$2.64M	Sell	47,771 -8,562	-15%	-$464K	0.42%	53
2025 Q4	$2.76M	Buy	56,333 +5,182	+10%	+$242K	0.45%	58
2025 Q3	$2.21M	Buy	51,151 +19,484	+62%	+$761K	0.37%	64
2025 Q2	$1.22M	Buy	+31,667	New	+$1.21M	0.22%	89
2022 Q2	–	Sell	-130	Closed	-$7K	–	519
2022 Q1	$7K	Sell	130 -298	-70%	-$16.2K	﹤0.01%	361
2021 Q4	$24K	Sell	428 -24	-5%	-$1.25K	0.01%	314
2021 Q3	$22K	Sell	452 -108	-19%	-$5.42K	0.01%	311
2021 Q2	$28K	Sell	560 -670	-54%	-$32.2K	0.01%	297
2021 Q1	$55K	Sell	1,230 -3,329	-73%	-$151K	0.03%	262
2020 Q4	$210K	Sell	4,559 -30,711	-87%	-$1.41M	0.13%	141
2020 Q3	$1.66M	Sell	35,270 -2,609	-7%	-$131K	1.1%	24
2020 Q2	$1.93M	Sell	37,879 -3,832	-9%	-$197K	1.45%	18
2020 Q1	$1.98M	Sell	41,711 -135	-0.3%	-$7.2K	1.78%	12
2019 Q4	$2.46M	Buy	41,846 +1,489	+4%	+$82.8K	1.79%	7
2019 Q3	$2.15M	Buy	40,357 +1,439	+4%	+$74K	1.62%	14
2019 Q2	$1.95M	Buy	38,918 +90	+0.2%	+$4.52K	1.55%	15
2019 Q1	$2.03M	Sell	38,828 -530	-1%	-$26.5K	1.58%	11
2018 Q4	$1.88M	Buy	39,358 +508	+1%	+$25K	1.6%	10
2018 Q3	$1.97M	Sell	38,850 -41	-0.1%	-$2.08K	1.48%	11
2018 Q2	$1.96M	Sell	38,891 -1,303	-3%	-$65.6K	1.5%	11
2018 Q1	$1.96M	Buy	40,194 +2,560	+7%	+$119K	1.58%	13
2017 Q4	$1.67M	Buy	37,634 +2,002	+6%	+$92.5K	1.31%	17
2017 Q3	$1.81M	Buy	35,632 +6,138	+21%	+$311K	1.47%	17
2017 Q2	$1.59M	Buy	29,494 +925	+3%	+$49.3K	1.35%	18
2017 Q1	$1.5M	Buy	28,569 +1,031	+4%	+$52.3K	1.3%	19
2016 Q4	$1.32M	Buy	+27,538	New	+$1.36M	1.21%	19

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

First Bank & Trust's GSK Position: Q2 2026 in Review

First Bank & Trust reduced its GSK (GSK) stake by 13% in Q2 2026, selling an estimated $331K and leaving 41,519 shares worth $2.18M. The position accounts for 0.32% of the portfolio, ranked #66.

First Bank & Trust first reported a position in GSK in Q4 2016 and has held it in 27 quarters since. The position peaked at $2.76M in Q4 2025. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

First Bank & Trust held 41,519 shares of GSK worth $2.18M as of Q2 2026.
First Bank & Trust sold 6,252 GSK shares in Q2 2026, an estimated $331K.
GSK made up 0.32% of First Bank & Trust's portfolio in Q2 2026, its #66 holding.
First Bank & Trust first reported a position in GSK in Q4 2016 and has held it in 27 quarters since.
First Bank & Trust's GSK position peaked at $2.76M in Q4 2025.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on First Bank & Trust's 13F filing for Q2 2026, filed 9 Jul 2026.